Cameco has become one of the most visible beneficiaries of the renewed interest in uranium and nuclear power.

In this week’s SVA Focus, Ross Healy takes a closer look at Cameco through the lens of Structural Valuation Analysis, examining both the strength of the long-term nuclear story and the valuation risk that may now be embedded in the stock.

Cameco’s move has been dramatic. From its lows during the March 2020 COVID market selloff, the stock recovered from what SVA identifies as its blue price, around 60% of book value, and climbed all the way toward what SVA classifies as its bubble or hypergrowth price, at approximately eight times unadjusted book value.

Along the way, the stock made several important valuation stops. It first moved to its growth price, held there for a period, and then advanced again to its super growth price as nuclear power regained acceptance and popularity in North America and Europe.

More recently, Cameco’s share price has been driven by another major theme: AI data centres and the enormous electricity demand they are expected to create.

In the short term, some of that demand may be met by natural gas. But over the longer term, nuclear power may play a larger role, particularly through small modular reactors and micro reactors. With hundreds of AI-related data centre projects reportedly in the planning stage, the market has clearly started to price in a powerful demand story for uranium and nuclear energy.

The challenge, however, is timing.

Nuclear power plants take years to develop. Ross notes that it can take roughly five years to bring a nuclear plant online, and a great deal can happen in that period. Even if higher uranium prices and increased nuclear demand do materialize over time, investors may need to wait for that growth to show up in Cameco’s earnings and fair market value.

That is where the SVA concern becomes clear.

Based on SVA’s work, Cameco’s fair market value is approximately $42, while the stock has recently been trading around $151. That is a significant gap between price and fair market value.

For investors, the key question is whether the market will remain patient while the nuclear demand story works its way through the system. If earnings growth does not arrive quickly enough, the current valuation may become difficult to support.

Ross also points out that a number of AI-related stocks have recently shown signs of weakness. If that weakness continues, it may eventually affect other stocks tied to the AI infrastructure theme, including Cameco.

If Cameco’s bubble price level, around $130, fails to hold, SVA’s historical work suggests that the gap between price and fair market value may begin to close.

That does not mean the long-term nuclear story is wrong. It means valuation still matters.

Popular themes can create powerful stock market moves, but they can also push prices well ahead of the fundamentals. For investors who own Cameco or other AI-related growth stocks, the question is not only whether the theme is real, but whether the current price already reflects too much optimism.

At Strategic Analysis, our focus is on helping investors protect and grow their equity wealth by identifying when stocks are attractively valued, fairly valued or trading at levels that may carry elevated risk.

Cameco may remain an important company in the global uranium and nuclear power market. But from an SVA perspective, the current valuation gap is too large to ignore.

Watch the full SVA Focus video here: https://youtu.be/T4K-CpvZ9e8

‍